Table 4.
Background characteristics of propensity score-matched patients with pN3 non-small cell lung cancer grouped by treatment
| Chemoradiation (n=221) (%) | Surgery (n=221) (%) | Std Mean Difference | p value | |
|---|---|---|---|---|
| Age (years, median) | 66(58–72) | 65(57–71) | −0.06 | 0.58 |
| Sex (female) | 96(43) | 105(48) | −0.08 | 0.45 |
| Race | 0.96 | |||
| White | 192(87) | 192(87) | ||
| Black | 22(10) | 21(10) | −0.01 | |
| Other | 7(3) | 8(4) | 0.02 | |
| Year of diagnosis, median (inter-quartile range) | 2010(2007–2012) | 2010(2007–2012) | −0.05 | 0.59 |
| CDCC Score | 0.99 | |||
| 0 | 137(62) | 138(62) | ||
| 1 | 62(28) | 62(28) | 0.00 | |
| 2+ | 22(10) | 21(10) | −0.01 | |
| Insurance status | 0.96 | |||
| Private | 89(40) | 88(40) | ||
| Government | 123(56) | 125(57) | 0.02 | |
| None | 9(4) | 8(4) | −0.02 | |
| Facility location | 0.24 | |||
| Metro | 189(86) | 176(80) | ||
| Urban | 25(11) | 33(15) | 0.10 | |
| Rural | 7(3) | 12(5) | 0.10 | |
| Academic center | 82(37) | 86(39) | 0.04 | |
| Tumor size, median (mm) | 28(18–39) | 30(19–40) | −0.01 | 0.77 |
| Histology | 0.85 | |||
| Adenocarcinoma | 141(64) | 139(63) | 0.44 | |
| Squamous cell carcinoma | 60(27) | 54(24) | −0.06 | |
| Other | 20(9) | 28(13) | 0.10 | |
| Perioperative chemotherapy | N/A | 163(74) | N/A | N/A |